Home >> Research Area >>Natural Products>> Schiarisanrin A

Schiarisanrin A

CAS# 130252-41-4

Schiarisanrin A

Catalog No. BCX0638----Order now to get a substantial discount!

Product Name & Size Price Stock
Schiarisanrin A: 5mg Please Inquire In Stock
Schiarisanrin A: 10mg Please Inquire In Stock
Schiarisanrin A: 20mg Please Inquire Please Inquire
Schiarisanrin A: 50mg Please Inquire Please Inquire
Schiarisanrin A: 100mg Please Inquire Please Inquire
Schiarisanrin A: 200mg Please Inquire Please Inquire
Schiarisanrin A: 500mg Please Inquire Please Inquire
Schiarisanrin A: 1000mg Please Inquire Please Inquire

Quality Control of Schiarisanrin A

Number of papers citing our products

Chemical structure

Schiarisanrin A

3D structure

Chemical Properties of Schiarisanrin A

Cas No. 130252-41-4 SDF Download SDF
PubChem ID 145709656.0 Appearance Powder
Formula C27H32O8 M.Wt 484.5
Type of Compound N/A Storage Desiccate at -20°C
Solubility Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc.
Chemical Name [(1S,12R,13R,14R)-18,19-dimethoxy-13,14-dimethyl-20-oxo-3,6,8-trioxapentacyclo[9.9.1.01,16.04,21.05,9]henicosa-4(21),5(9),10,16,18-pentaen-12-yl] (2S)-2-methylbutanoate
SMILES CCC(C)C(=O)OC1C(C(CC2=CC(=C(C(=O)C23COC4=C3C1=CC5=C4OCO5)OC)OC)C)C
Standard InChIKey JHTGXHCLRHKLER-ZPNZURAVSA-N
Standard InChI InChI=1S/C27H32O8/c1-7-13(2)26(29)35-21-15(4)14(3)8-16-9-18(30-5)23(31-6)25(28)27(16)11-32-24-20(27)17(21)10-19-22(24)34-12-33-19/h9-10,13-15,21H,7-8,11-12H2,1-6H3/t13-,14+,15+,21+,27-/m0/s1
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Schiarisanrin A Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

Schiarisanrin A Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of Schiarisanrin A

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 2.064 mL 10.3199 mL 20.6398 mL 41.2797 mL 51.5996 mL
5 mM 0.4128 mL 2.064 mL 4.128 mL 8.2559 mL 10.3199 mL
10 mM 0.2064 mL 1.032 mL 2.064 mL 4.128 mL 5.16 mL
50 mM 0.0413 mL 0.2064 mL 0.4128 mL 0.8256 mL 1.032 mL
100 mM 0.0206 mL 0.1032 mL 0.2064 mL 0.4128 mL 0.516 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University
Featured Products
New Products
 

References on Schiarisanrin A

Schizandra arisanensis extract attenuates cytokine-mediated cytotoxicity in insulin-secreting cells.[Pubmed:23239919]

World J Gastroenterol. 2012 Dec 14;18(46):6809-18.

AIM: To explore the bioactivity of an ethanolic extract of Schizandra arisanensis (SA-Et) and isolated constituents against interleukin-1beta and interferon-gamma-mediated beta cell death and abolition of insulin secretion. METHODS: By employing BRIN-BD11 cells, the effects of SA-Et administration on cytokine-mediated cell death and abolition of insulin secretion were evaluated by a viability assay, cell cycle analysis, and insulin assay. The associated gene and protein expressions were also measured. In addition, the bioactivities of several peak compounds collected from the SA-Et were tested against cytokine-mediated beta cell death. RESULTS: Our results revealed that SA-Et dose-dependently ameliorated cytokine-mediated beta cell death and apoptosis. Instead of suppressing inducible nitric oxide synthase/nitric oxide cascade or p38MAPK activity, suppression of stress-activated protein kinase/c-Jun NH2-terminal kinase activity appeared to be the target for SA-Et against the cytokine mix. In addition, SA-Et provided some insulinotropic effects which re-activated the abolished insulin exocytosis in cytokine-treated BRIN-BD11 cells. Finally, Schiarisanrin A and B isolated from the SA-Et showed a dose-dependent protective effect against cytokine-mediated beta cell death. CONCLUSION: This is the first report on SA-Et ameliorating cytokine-mediated beta cell death and dysfunction via anti-apoptotic and insulinotropic actions.

Four New C19 Homolignans, Schiarisanrins A, B, and D and Cytotoxic Schiarisanrin C, from Schizandra arisanensis.[Pubmed:11671710]

J Org Chem. 1997 May 16;62(10):3242-3245.

Four new C(19) homolignans with a 5,4'-butano-2,4-cyclohexadienone-6-spiro-3'-(2',3'-dihydrobenzo[b]furan) skeleton, Schiarisanrin A, schiarisanrin B, schiarisanrin D, and cytotoxic schiarisanrin C, were isolated from Schizandra arisanensis. Their structure and stereochemistry have been established by spectral and single-crystal X-ray analysis. Schiarisanrin C has cytotoxic activity with ED(50) values of 0.36, 7.1, 4.9, and 5.7 &mgr;g/mL, respectively, against KB epidermoid carcinoma of nasopharynx, COLO-205 colon carcinoma, HEPA hepatoma, and HELA cervix tumor cells.

Keywords:

Schiarisanrin A,130252-41-4,Natural Products, buy Schiarisanrin A , Schiarisanrin A supplier , purchase Schiarisanrin A , Schiarisanrin A cost , Schiarisanrin A manufacturer , order Schiarisanrin A , high purity Schiarisanrin A

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: